Conmed (CNMD) Payables (2010 - 2026)

Conmed (CNMD) has reported Payables for 17 consecutive years, with $101.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Payables changed 0.04% year-over-year to $101.0 million; the trailing twelve-month figure through Jun 2026 stood at $101.0 million (changed 0.04% YoY), and the FY2025 full-year result was $93.6 million, down 8.41% from the prior year.
• Payables declined to $101.0 million in Q2 2026 per CNMD's latest filing, from $105.4 million in the prior quarter.
• Across five years, Payables topped out at $107.1 million in Q3 2025 and bottomed at $67.5 million in Q1 2022.
• Historically, Payables has averaged $90.4 million across 5 years, with a median of $94.7 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Payables soared 59.3% in 2022, then fell 8.41% in 2025.
• Over 5 years, Payables stood at $73.4 million in 2022, then increased by 20.21% to $88.2 million in 2023, then rose by 15.9% to $102.2 million in 2024, then decreased by 8.41% to $93.6 million in 2025, then rose by 7.87% to $101.0 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $101.0 million, $105.4 million, and $93.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.